Literature DB >> 24600003

Coronaviruses: important emerging human pathogens.

Christopher M Coleman1, Matthew B Frieman.   

Abstract

The identification of Middle East respiratory syndrome coronavirus (MERS-CoV) in 2012 reaffirmed the importance of understanding how coronaviruses emerge, infect, and cause disease. By comparing what is known about severe acute respiratory syndrome coronavirus (SARS-CoV) to what has recently been found for MERS-CoV, researchers are discovering similarities and differences that may be important for pathogenesis. Here we discuss what is known about each virus and what gaps remain in our understanding, especially concerning MERS-CoV.

Entities:  

Mesh:

Year:  2014        PMID: 24600003      PMCID: PMC4019136          DOI: 10.1128/JVI.03488-13

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  18 in total

1.  Molecular evolution of the SARS coronavirus during the course of the SARS epidemic in China.

Authors: 
Journal:  Science       Date:  2004-01-29       Impact factor: 47.728

2.  Molecular evolution analysis and geographic investigation of severe acute respiratory syndrome coronavirus-like virus in palm civets at an animal market and on farms.

Authors:  Biao Kan; Ming Wang; Huaiqi Jing; Huifang Xu; Xiugao Jiang; Meiying Yan; Weili Liang; Han Zheng; Kanglin Wan; Qiyong Liu; Buyun Cui; Yanmei Xu; Enmin Zhang; Hongxia Wang; Jingrong Ye; Guichang Li; Machao Li; Zhigang Cui; Xiaobao Qi; Kai Chen; Lin Du; Kai Gao; Yu-Teng Zhao; Xiao-Zhong Zou; Yue-Ju Feng; Yu-Fan Gao; Rong Hai; Dongzhen Yu; Yi Guan; Jianguo Xu
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

3.  Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia.

Authors:  Ali M Zaki; Sander van Boheemen; Theo M Bestebroer; Albert D M E Osterhaus; Ron A M Fouchier
Journal:  N Engl J Med       Date:  2012-10-17       Impact factor: 91.245

4.  Middle East respiratory syndrome coronavirus spike protein delivered by modified vaccinia virus Ankara efficiently induces virus-neutralizing antibodies.

Authors:  Fei Song; Robert Fux; Lisette B Provacia; Asisa Volz; Markus Eickmann; Stephan Becker; Albert D M E Osterhaus; Bart L Haagmans; Gerd Sutter
Journal:  J Virol       Date:  2013-08-28       Impact factor: 5.103

5.  Middle East respiratory syndrome coronavirus (MERS-CoV) causes transient lower respiratory tract infection in rhesus macaques.

Authors:  Emmie de Wit; Angela L Rasmussen; Darryl Falzarano; Trenton Bushmaker; Friederike Feldmann; Douglas L Brining; Elizabeth R Fischer; Cynthia Martellaro; Atsushi Okumura; Jean Chang; Dana Scott; Arndt G Benecke; Michael G Katze; Heinz Feldmann; Vincent J Munster
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-23       Impact factor: 11.205

6.  Receptor-binding domain as a target for developing SARS vaccines.

Authors:  Xiaojie Zhu; Qi Liu; Lanying Du; Lu Lu; Shibo Jiang
Journal:  J Thorac Dis       Date:  2013-08       Impact factor: 2.895

7.  Antibodies to SARS coronavirus in civets.

Authors:  Changchun Tu; Gary Crameri; Xiangang Kong; Jinding Chen; Yanwei Sun; Meng Yu; Hua Xiang; Xianzhu Xia; Shengwang Liu; Tao Ren; Yedong Yu; Bryan T Eaton; Hua Xuan; Lin-Fa Wang
Journal:  Emerg Infect Dis       Date:  2004-12       Impact factor: 6.883

8.  The Middle East respiratory syndrome coronavirus (MERS-CoV) does not replicate in Syrian hamsters.

Authors:  Emmie de Wit; Joseph Prescott; Laura Baseler; Trenton Bushmaker; Tina Thomas; Matthew G Lackemeyer; Cynthia Martellaro; Shauna Milne-Price; Elaine Haddock; Bart L Haagmans; Heinz Feldmann; Vincent J Munster
Journal:  PLoS One       Date:  2013-07-02       Impact factor: 3.240

9.  Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans.

Authors:  Sander van Boheemen; Miranda de Graaf; Chris Lauber; Theo M Bestebroer; V Stalin Raj; Ali Moh Zaki; Albert D M E Osterhaus; Bart L Haagmans; Alexander E Gorbalenya; Eric J Snijder; Ron A M Fouchier
Journal:  MBio       Date:  2012-11-20       Impact factor: 7.867

Review 10.  A review of studies on animal reservoirs of the SARS coronavirus.

Authors:  Zhengli Shi; Zhihong Hu
Journal:  Virus Res       Date:  2007-04-23       Impact factor: 3.303

View more
  87 in total

1.  A synthetic consensus anti-spike protein DNA vaccine induces protective immunity against Middle East respiratory syndrome coronavirus in nonhuman primates.

Authors:  Karuppiah Muthumani; Darryl Falzarano; Emma L Reuschel; Colleen Tingey; Seleeke Flingai; Daniel O Villarreal; Megan Wise; Ami Patel; Abdullah Izmirly; Abdulelah Aljuaid; Alecia M Seliga; Geoff Soule; Matthew Morrow; Kimberly A Kraynyak; Amir S Khan; Dana P Scott; Friederike Feldmann; Rachel LaCasse; Kimberly Meade-White; Atsushi Okumura; Kenneth E Ugen; Niranjan Y Sardesai; J Joseph Kim; Gary Kobinger; Heinz Feldmann; David B Weiner
Journal:  Sci Transl Med       Date:  2015-08-19       Impact factor: 17.956

2.  Human Coronavirus HKU1 Spike Protein Uses O-Acetylated Sialic Acid as an Attachment Receptor Determinant and Employs Hemagglutinin-Esterase Protein as a Receptor-Destroying Enzyme.

Authors:  Xingchuan Huang; Wenjuan Dong; Aleksandra Milewska; Anna Golda; Yonghe Qi; Quan K Zhu; Wayne A Marasco; Ralph S Baric; Amy C Sims; Krzysztof Pyrc; Wenhui Li; Jianhua Sui
Journal:  J Virol       Date:  2015-04-29       Impact factor: 5.103

3.  Hospital-based zoonotic disease surveillance in Bangladesh: design, field data and difficulties.

Authors:  Pritimoy Das; Hossain M S Sazzad; Mohammad Abdul Aleem; M Ziaur Rahman; Mahmudur Rahman; Simon J Anthony; W Ian Lipkin; Emily S Gurley; Stephen P Luby; John J Openshaw
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2019-08-12       Impact factor: 6.237

4.  Protective Efficacy of Recombinant Modified Vaccinia Virus Ankara Delivering Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein.

Authors:  Asisa Volz; Alexandra Kupke; Fei Song; Sylvia Jany; Robert Fux; Hosam Shams-Eldin; Jörg Schmidt; Christin Becker; Markus Eickmann; Stephan Becker; Gerd Sutter
Journal:  J Virol       Date:  2015-05-27       Impact factor: 5.103

5.  Machine Learning Models Identify Inhibitors of SARS-CoV-2.

Authors:  Victor O Gawriljuk; Phyo Phyo Kyaw Zin; Ana C Puhl; Kimberley M Zorn; Daniel H Foil; Thomas R Lane; Brett Hurst; Tatyana Almeida Tavella; Fabio Trindade Maranhão Costa; Premkumar Lakshmanane; Jean Bernatchez; Andre S Godoy; Glaucius Oliva; Jair L Siqueira-Neto; Peter B Madrid; Sean Ekins
Journal:  J Chem Inf Model       Date:  2021-08-13       Impact factor: 6.162

6.  A Mouse-Adapted Model of HCoV-OC43 and Its Usage to the Evaluation of Antiviral Drugs.

Authors:  Peifang Xie; Yue Fang; Zulqarnain Baloch; Huanhuan Yu; Zeyuan Zhao; Rongqiao Li; Tongtong Zhang; Runfeng Li; Jincun Zhao; Zifeng Yang; Shuwei Dong; Xueshan Xia
Journal:  Front Microbiol       Date:  2022-05-17       Impact factor: 6.064

Review 7.  Continuous and Discontinuous RNA Synthesis in Coronaviruses.

Authors:  Isabel Sola; Fernando Almazán; Sonia Zúñiga; Luis Enjuanes
Journal:  Annu Rev Virol       Date:  2015-11       Impact factor: 10.431

Review 8.  Epidemiology of coronaviruses, genetics, vaccines, and scenario of current pandemic of coronavirus diseases 2019 (COVID-19): a fuzzy set approach.

Authors:  Fazal Mehmood Khan; Tauseef Ahmad; Muhammad Gulistan; Wathek Chammam; Muhammad Khan; Jin Hui
Journal:  Hum Vaccin Immunother       Date:  2021-03-15       Impact factor: 3.452

Review 9.  Functions of Coronavirus Accessory Proteins: Overview of the State of the Art.

Authors:  Puxian Fang; Liurong Fang; Huichang Zhang; Sijin Xia; Shaobo Xiao
Journal:  Viruses       Date:  2021-06-13       Impact factor: 5.048

Review 10.  Future Challenges of Covid-19 and Oral Manifestations in Daily Dental Practice: A Literature Review.

Authors:  Grecia Riofrio; Stephanny Castillo; Gabriela Salcedo; Daniel Alvitez-Temoche; Romel Watanabe; Frank Mayta-Tovalino
Journal:  J Int Soc Prev Community Dent       Date:  2021-06-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.